Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a **combination topical formulation consisting of tea tree oil, rosemary oil, clove oil, pepper oil, and limonene**. Each component is an essential oil widely recognized for its natural bioactive constituents. The combination is being investigated as a *topical therapy*, particularly as a skin-permeation-enhancing blend for localized relief such as in plantar fasciitis, based on available clinical trial data[1]. - **Tea tree oil** (*Melaleuca alternifolia* oil): Contains active terpenes such as α-pinene and limonene and demonstrates antimicrobial, anti-inflammatory, and local anesthetic activities, largely through disruption of microbial cell membranes and modulation of inflammatory mediators[3][4]. - **Rosemary oil** (*Rosmarinus officinalis* oil): Exhibits antinociceptive (pain-relieving), antioxidant, and anti-inflammatory properties through its phenolic compounds and terpenes. - **Clove oil** (*Syzygium aromaticum* oil): Rich in eugenol, a compound with well-documented analgesic (pain-relieving), antimicrobial, and anti-inflammatory activities mainly via membrane disruption and enzymatic inhibition pathways. - **Pepper oil** (commonly *Piper nigrum* oil): Demonstrates local stimulation, warming, and possibly analgesic and anti-microbial effects, attributed to piperine and related alkaloids. - **Limonene** (a monoterpene): Potent skin penetration enhancer; fluidizes stratum corneum lipids, increasing transdermal drug delivery[2]. Limonene also has mild anti-inflammatory and local anesthetic actions. The mechanism of the combination is *multimodal*: facilitating enhanced transdermal penetration (through stratum corneum lipid disruption primarily via limonene and other terpenes), provision of local anti-inflammatory and analgesic actions, and broad-spectrum antimicrobial activity[2][3][4]. The product is not an approved pharmaceutical drug and is referred to in clinical study contexts primarily as a topical experimental blend for symptom relief.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tea tree oil + rosemary oil + clove oil + pepper oil + limonene.